XML 15 R6.htm IDEA: XBRL DOCUMENT v3.22.2
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Unaudited) - USD ($)
Total
Common Stock
Additional Paid In Capital
Accumulated Deficit
Accumulated Other Comprehensive Loss
Beginning balance at Dec. 31, 2020 $ 338,931,000 $ 3,000 $ 482,955,000 $ (144,066,000) $ 39,000
Beginning balance, shares at Dec. 31, 2020   26,988,458      
Issuance of common stock 270,017,000   270,017,000    
Issuance of common stock, shares   2,395,834      
Stock-based compensation expense 5,822,000   5,822,000    
Exercise of common options 671,000   671,000    
Exercise of common options, shares   56,876      
Other comprehensive income (loss) (30,000)       (30,000)
Net loss (30,497,000)     (30,497,000)  
Ending balance at Mar. 31, 2021 584,914,000 $ 3,000 759,465,000 (174,563,000) 9,000
Ending balance, shares at Mar. 31, 2021   29,441,168      
Beginning balance at Dec. 31, 2020 338,931,000 $ 3,000 482,955,000 (144,066,000) 39,000
Beginning balance, shares at Dec. 31, 2020   26,988,458      
Net loss (64,913,000)        
Ending balance at Jun. 30, 2021 560,338,000 $ 3,000 769,319,000 (208,979,000) (5,000)
Ending balance, shares at Jun. 30, 2021   29,543,810      
Beginning balance at Mar. 31, 2021 584,914,000 $ 3,000 759,465,000 (174,563,000) 9,000
Beginning balance, shares at Mar. 31, 2021   29,441,168      
Stock-based compensation expense 7,466,000   7,466,000    
Exercise of common options 2,388,000   2,388,000    
Exercise of common options, shares   102,642      
Other comprehensive income (loss) (14,000)       (14,000)
Net loss (34,416,000)     (34,416,000)  
Ending balance at Jun. 30, 2021 560,338,000 $ 3,000 769,319,000 (208,979,000) (5,000)
Ending balance, shares at Jun. 30, 2021   29,543,810      
Beginning balance at Dec. 31, 2021 502,026,000 $ 3,000 790,391,000 (287,871,000) (497,000)
Beginning balance, shares at Dec. 31, 2021   29,770,558      
Stock-based compensation expense 10,636,000   10,636,000    
Exercise of common options 1,282,000   1,282,000    
Exercise of common options, shares   60,700      
Other comprehensive income (loss) (2,038,000)       (2,038,000)
Net loss (58,218,000)     (58,218,000)  
Ending balance at Mar. 31, 2022 453,688,000 $ 3,000 802,309,000 (346,089,000) (2,535,000)
Ending balance, shares at Mar. 31, 2022   29,831,258      
Beginning balance at Dec. 31, 2021 $ 502,026,000 $ 3,000 790,391,000 (287,871,000) (497,000)
Beginning balance, shares at Dec. 31, 2021   29,770,558      
Exercise of common options, shares 162,545        
Net loss $ (123,161,000)        
Ending balance at Jun. 30, 2022 405,409,000 $ 3,000 819,433,000 (411,032,000) (2,995,000)
Ending balance, shares at Jun. 30, 2022   29,933,103      
Beginning balance at Mar. 31, 2022 453,688,000 $ 3,000 802,309,000 (346,089,000) (2,535,000)
Beginning balance, shares at Mar. 31, 2022   29,831,258      
Stock-based compensation expense 12,132,000   12,132,000    
Exercise of common options 4,992,000   4,992,000    
Exercise of common options, shares   101,845      
Other comprehensive income (loss) (460,000)       (460,000)
Net loss (64,943,000)     (64,943,000)  
Ending balance at Jun. 30, 2022 $ 405,409,000 $ 3,000 $ 819,433,000 $ (411,032,000) $ (2,995,000)
Ending balance, shares at Jun. 30, 2022   29,933,103